GlobeNewswire Inc | Feb 25, 2021 11:00AM EST

February 25, 2021

LOS ANGELES, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to fcruz@frankcruzlaw.com.

bluebird bio, Inc. (NASDAQ: BLUE)Class Period: May 11, 2020 November 4, 2020Lead Plaintiff Deadline: April 13, 2021

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) data supporting bluebird's BLA submission for LentiGlobin for SCD was insufficient to demonstrate drug product comparability; (2) Defendants downplayed the foreseeable impact of disruptions related to the COVID-19 pandemic on the Company's BLA submission schedule for LentiGlobin for SCD, particularly with respect to manufacturing; (3) as a result of all the foregoing, it was foreseeable that the Company would not submit the BLA for LentiGlobin for SCD in the second half of 2021; and (4) as a result, Defendants positive statements about the Companys business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

EHang Holdings Limited (NASDAQ: EH)Class Period: December 12, 2019 February 16, 2021Lead Plaintiff Deadline: April 19, 2021

Shareholders with $10,000 losses or more are encouraged to contact the firm

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the Companys purported regulatory approvals in Europe and North America for its EH216 were for use as a drone, and not for carrying passengers; (2) its relationship with its purported primary customer is a sham; (3) EHang has only collected on a fraction of its reported sales since its ADS began trading on NASDAQ in December 2019; (4) the Companys manufacturing facilities were practically empty and lacked evidence of advanced manufacturing equipment or employees; and (5) as a result, Defendants statements about its business, operations, and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.

Jianpu Technology, Inc. (NYSE: JT)Class Period: May 29, 2018 February 16, 2021Lead Plaintiff Deadline: April 19, 2021

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that certain of the Companys transactions carried out by the Credit Card Recommendation Business Unit involved undisclosed relationships or lacked business substance; (2) that, as a result, Jianpus revenue and costs and expenses for fiscal 2018 and 2019 were overstated; (3) that there were material weaknesses in Jianpus internal control over financial reporting; (4) that, as a result of the foregoing, the Companys fiscal 2018 Form 20-F was reasonably likely to be restated; and (5) that, as a result of the foregoing, Defendants positive statements about the Companys business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Immunovant, Inc. (NASDAQ: IMVT)Class Period: October 2, 2019 February 1, 2021Lead Plaintiff Deadline: April 20, 2021

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) Fubos growth in subscriber and profitability was unsustainable past the seasonal surge in subscription levels; (2) Fubos offering of products was subject to undisclosed cost escalations; (3) Fubo could not successfully compete and perform as sports book operator and could not capitalize on its online sports wagering opportunity; (4) Fubos data and inventory was not differentiated to allow Fubo to achieve its long-term advertising growth and forecasts; (5) Fubos valuation was overstated in light of its total revenue and subscription levels; and (6) the acquisition of Balto Sports did not provide the stated synergies and internal expertise, and did not expand the Companys addressable market into sports wagering.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish tolearn moreabout these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz, 310-914-5007fcruz@frankcruzlaw.comwww.frankcruzlaw.com